Huons Dapagliflozin 5mg (Dapagliflozin Monohydrate Blend)

Adult dose

The recommended dose for this medication as monotherapy and in combination with other antidiabetic agents, such as insulin, is 10mg once daily. In the case of initial combination therapy with metformin, the initial recommended doses are 5mg or 10mg once daily. This medication can be orally administered at any time of the day regardless of food intake. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. There are no related data.

This medication should not be used in patients who are hypersensitive to the active ingredients or excipients. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. This medication contains anhydrous lactose, which should not be given to patients with genetic conditions such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Patients undergoing dialysis should not use this medication. Patients with reduced fluid volume or renal impairment should use this medication cautiously, as it may cause hypotension or rapid changes in kidney function. Especially in older patients or those taking diuretics and with poor kidney function, blood pressure and kidney function should be monitored frequently. This medication contains Yellow No. 4 and Yellow No. 5 dyes, so patients allergic or hypersensitive to these components should exercise caution. This medication may increase the risk of genital infections and urinary tract infections; if related symptoms appear, immediate treatment should be sought. Due to the risk of hypoglycemia, dosage adjustments may be required when used with insulin or sulfonylureas. During treatment, symptoms such as dizziness, dry mouth, constipation, back pain, and dysuria may occur; if unusual symptoms persist, consult a physician. It is advisable for pregnant or breastfeeding women to avoid this medication and to discontinue it immediately if pregnancy is confirmed. There is no specific antidote for overdose, so it is important to receive symptom-appropriate treatment. This medication does not significantly affect driving or machine operation, but caution is necessary due to potential hypoglycemic symptoms. Store this medication out of reach of children and in its original container.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash accompanied by fever, blistering, peeling skin, oral/ocular mucous membrane pain, shortness of breath or difficulty breathing, asthma attacks, abnormal respiratory patterns with cough + fever, yellowing of skin or eyes (jaundice), severe lethargy, sudden and severe headache, lightning headache, seizures, consciousness confusion, visual disturbances, paralysis, and urination difficulties.

Mild side effects

Vulvitis, balanitis and associated genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, increased hematocrit, reduced creatinine clearance in the initial stages of treatment, dyslipidemia, elevated blood creatinine, increased blood urea, weight loss, urticaria, cold sweat, dermatitis, and dry skin.

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the medication's effectiveness for a longer period.

Appearance

Yellow, biconvex, film-coated tablet with a round shape

Package unit

28 tablets/box [(7 tablets/PTP×4)]